Han Zhu, MD, Stanford University, Standford, CA, discusses remaining challenges in reducing or preventing cardiotoxicity in patients receiving immunotherapy.
See more from VJ Oncology
🎥 @HanZhuMD of @Stanford discusses remaining challenges in reducing or preventing cardiotoxicity in patients receiving immunotherapy Watch: 👉https://t.co/fnDyhK5oG6👈 @sitcancer #SITC2022 #SITC22 #ImmunoOnc - view on twitter